Grewal Eye Institute First to offer C3R Crosslinking Treatment in the Entire Indian Sub-Continent
Grewal Eye Institute (GEI) has become the first and the only institute, in the whole Indian Sub-Continent to offer the revolutionary *'Collagen Crosslinking with Riboflavin' (C3R) Treatment* to the masses. The C3R procedure, the only known treatment that can permanently halt the progression of the dreaded Keratoconus disease. GEI, now, offers comprehensive treatment for this previously untreatable disease.
Tweet-- C3R Crosslinking, Latest Advancement in Ophthalmology, Internationally Launched This Month, Ray of Hope for Lacs of Indian Keratoconus Patients
Grewal Eye Institute (GEI), the premier comprehensive Eye Care Institute based at Chandigarh, has achieved a new high in bringing the latest technological advancement in the field of eye care, by becoming the first and the only institute, not only in India, but in the whole Indian Sub-Continent to offer the revolutionary ‘Corneal Collagen Crosslinking with Riboflavin’ (C3R) Treatment to the masses. The C3R procedure, the only known treatment that has recently been proven to permanently halt the progression of the dreaded Keratoconus disease, was commercially launched globally in the second week of this month itself. By procuring this once-in-a-decade technological break-through in less than two weeks of its launch, GEI is now one of the few eye institutes in the world and the only in Indian subcontinent, to offer comprehensive treatment now available for this previously untreatable disease. This was announced here today by Dr. SPS Grewal, CEO, GEI.
The C3R Treatment is a ray of hope for lacs of Indian Keratoconus Patients, who, before the launch of this advanced procedure, were resigned to the vagaries of fate. This is because Keratoconus is amongst the most dreaded of eye diseases, as in most of the cases, the disease progresses relentlessly during the young age, does not have any acute symptoms initially and thus is often not detected in the early stages. In the advanced stages, the only treatment options available earlier were surgical insertion of ‘Intacs’ or a ‘Corneal Transplant’, both of which have limited success on many grounds, like trauma to the eye, numerous precautions required post-surgery and a long recovery period etc. Most importantly, from both the doctors’ & patients’ perspective, neither of the operations guaranteed a stoppage of the disease. There was always the possibility of setting in of Keratoconus again, even after the operation. This made the situation a frustrating one for both the patient and the doctor.
Speaking at the press conference Dr S.P.S. Grewal, (CEO), GEI said, “C3R is a non-surgical procedure. Also it is the only known procedure that is proven to halt the progression of the dreaded Keratoconus. This treatment now offers an end to a lifetime of waiting and uncertainty for Keratoconus patients. This is a simple one-time treatment that offers a permanent solution to Keratoconus. It does not need heavy precautions or regular follow-up visits, does not need an eye donor as required in ‘Corneal Transplant’, does not require any stitches or incision in the eye, takes just around one hour and the patient recovery is quick. This procedure is a boon for patients with keratoconus”.
Keratoconus weakens the cornea of the eye causing the eye to bulge outwards and producing moderate to severe blurriness of vision. In the C3R procedure, the eye is impregnated with a riboflavin solution and exposed to ultra-high frequency light. C3R causes the collagen fibrils to thicken, stiffen, and crosslink & re-attach to each other, making the cornea stronger and more stable thus convincingly halting the progression of the disease. This technique can also be used in corneal ulcers and before LASIK treatment in high Myopes to reduce the risk of postoperative Keratectasia.
Like all treatments, this procedure is most beneficial when performed at the earliest possible stage of Keratoconus when the visual and mechanical damage to the cornea is minimal. This is where the role of modern topography devices such as the Pentacam lies. The Pentacam helps to detect Keratoconus much before it can be detected in a clinical examination and ensures that the disease is permanently halted by C3R before any serious damage to the eye.
The C3R procedure was launched internationally at the 24th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) held at London from September 9-13, 2006 where Dr SPS Grewal and team presented their research work on Pentacam.
Speaking at the press conference DR SPS Grewal said, “It is always our endeavour to bring the best, safest and the latest technologies & advancements in the field of eye care to patients in our region. The continued faith, patronage and trust of our patients in the region, nationally and internationally, inspires us to continue to push the limits of excellence and community service here at GEI. We are very happy to be the first and only institute in the Indian Sub-Continent to offer the C3R procedure. For the field of Opthhalmology the treatment of Keratoconus is as significant as bypass surgery or angioplasty in cardiology. It is matter of great satisfaction to us that our patients will be amongst the first to benefit from this revolutionary procedure. Today we reaffirm our commitment to lead the way in procuring and advancing cutting-edge solutions to eye diseases.” ***
Notes to Editor
InfoMailers.com is the first ever Indian Website that boasts of the largest number of membership from the media fraternity, who have consented to receive news items by email. It, probable, also has the largest number of Indian Net Users as its members (exceeding 3,00,000) and growing by the second.
InfoMailers.com disseminates news item by mail in English, Hindi & Punjabi on a real time basis to its members across India and across Print, Electronic and Internet Media, apart from more than 3,00,000 Indian net users.